Root, Inc. Form 8-K Summary
Business Context and Reporting Period
Root, Inc. filed this Current Report on August 12, 2022, reporting corporate actions affecting its common stock, equity plans, preferred stock, and warrants. The filing does not provide quarterly or annual operating results.
Material Corporate Action
Effective at 5:00 p.m. Eastern time on August 12, 2022, Root implemented a one-for-eighteen reverse stock split of its Class A and Class B common stock.
- Each 18 pre-split shares were converted into one share.
- Class A common stock began trading on a split-adjusted basis on Nasdaq on August 15, 2022, under the existing symbol ROOT.
- The post-split shares were assigned a new CUSIP: 77664L 207.
- Shares registered on applicable SEC registration statements were proportionately reduced.
- Anti-dilution adjustments were made to the 2020 Equity Incentive Plan, the amended and restated 2015 Equity Incentive Plan, the 2020 Employee Stock Purchase Plan, and outstanding awards under those plans.
- The conversion price of the Series A Convertible Preferred Stock and the exercise prices and share amounts associated with outstanding warrants were proportionately adjusted.
Financial Metrics, Liquidity, and Outlook
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, guidance, or operating outlook. It contains no management commentary on financial performance or business prospects.
Risks, Contingencies, and Unusual Items
The reverse stock split may affect share counts, per-share trading prices, equity compensation awards, preferred-stock conversion terms, and warrant economics. The filing does not describe additional contingencies or quantify the effect on dilution or capitalization.
Key Facts for Investors to Verify
- Confirm the one-for-eighteen reverse split effective time and the first split-adjusted trading date.
- Review the Certificate of Amendment filed as Exhibit 3.1 for the complete legal terms.
- Verify post-split share counts and any fractional-share treatment in the governing documents or related disclosures.
- Review adjusted equity-plan award quantities, warrant exercise prices and share amounts, and Series A conversion terms.
- Assess subsequent filings for updated capitalization, dilution, financial results, and any market or compliance effects of the reverse split.